Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
03/25/1987 | EP0215297A2 Substituted dipeptide amides |
03/25/1987 | EP0215171A2 Peptides |
03/25/1987 | EP0215131A1 E87Ag ANTIGEN OF PSEUDOMONAS AERUGINOSA, MONOCLONAL ANTIBODY AGAINST IT, AND HYBRIDOMA |
03/25/1987 | EP0215126A1 Human granulocyte colony stimulating factor |
03/25/1987 | EP0215081A1 Preparations of immunoglobulines presenting high titres of blocking antibodies |
03/25/1987 | EP0215050A1 Purification of blood coagulation factor viii by precipitation. |
03/24/1987 | US4652627 Blood metal concentrations |
03/24/1987 | US4652552 Tetrapeptide methyl ketone inhibitors of viral proteases |
03/24/1987 | US4652551 Peptide, hypotensive |
03/24/1987 | US4652550 Inhibiting release of gonadotropins; peptides |
03/24/1987 | US4652549 Cardiac anti-hypertrophic agents |
03/24/1987 | US4652548 Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin |
03/24/1987 | US4652547 Pharmaceutical formulations comprising human insulin and human proinsulin |
03/24/1987 | US4652449 Encapsulating biological active substances into erythrocytes |
03/24/1987 | US4652448 Use of monoclonal antibodies against bacterial adhesins |
03/24/1987 | US4652447 Methods and compositions using monoclonal antibody to human helper T cells |
03/24/1987 | US4652443 Slow-release composite and process for producing the same |
03/24/1987 | US4652441 Water soluble drugs |
03/24/1987 | CA1219587A1 Hydroxybenzylaminobenzenes as anti-inflammatory agents |
03/18/1987 | EP0214924A2 Oxytocin and antigestagene for the induction of labour |
03/18/1987 | EP0214872A2 Somatostatin analoge |
03/18/1987 | EP0214853A2 Viscoelastic collagen solution for ophthalmic use and method of preparation |
03/18/1987 | EP0214826A2 Insulin analogues and method of preparing the same |
03/18/1987 | EP0214737A1 Method for producing a composition for controlling bleeding |
03/18/1987 | EP0214709A2 Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of AIDS and pre-AIDS conditions and as a vaccine |
03/18/1987 | EP0214659A2 Peptide derivatives, process for the production thereof and pharmaceutical compositions containing same |
03/18/1987 | EP0214639A2 Hydroxamic acid based collagenase inhibitors |
03/18/1987 | EP0214570A2 N-alkylated tripeptides, process for their preparation, medicaments containing them and their use |
03/18/1987 | EP0214265A1 Antigens, antibodies and their uses |
03/18/1987 | CN85109736A Mfr. method and the composition of new peptide-aldehyde compound |
03/18/1987 | CN85106564A Process for preparing polypeptide related to alpha-human afrial natriuretic polypeptide |
03/17/1987 | US4650858 Precipitation with polyoxyethylene glycol |
03/17/1987 | US4650855 Derived from teichoplanin |
03/17/1987 | US4650854 Osteoporosis |
03/17/1987 | US4650788 Novel peptides having an immunostimulating action, processes for their preparation and their use |
03/17/1987 | US4650787 Biologically active octapeptides |
03/17/1987 | US4650786 Hemoglobin compounds |
03/17/1987 | US4650785 Pharmaceutical composition having an excellent absorption property |
03/17/1987 | US4650678 Readily dissolvable lyophilized fibrinogen formulation |
03/17/1987 | US4650674 Tumor necrosis factor and interferon |
03/17/1987 | US4650661 Enzyme inhibitors |
03/17/1987 | CA1219234A1 Methods of purification and reactivation of precipitated heterologous proteins |
03/17/1987 | CA1219211A1 Stabilized gamma globulin concentrate |
03/16/1987 | EP0198921A4 Biologically-active xanthine derivatives. |
03/12/1987 | WO1987001387A1 A superoxide dismutase |
03/12/1987 | WO1987001375A1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used |
03/12/1987 | WO1987001374A2 Method and means for sorting and identifying biological information |
03/12/1987 | WO1987001372A1 cDNA AND GENE FOR HUMAN ANGIOGENIN (ANGIOGENESIS FACTOR) AND METHODS OF EXPRESSION |
03/12/1987 | WO1987001288A1 Process for treatment of allergies |
03/12/1987 | WO1987001286A1 Medicinal composition |
03/12/1987 | WO1986003125A3 Use of purified lipopolysaccharides and their derivatives |
03/11/1987 | EP0214057A1 Lectin attachment factors of Neisseria gonorrhoeae, method for their preparation and therapeutic composition containing these lectins, the corresponding antibodies or the corresponding attachment receptors |
03/11/1987 | EP0214035A1 Placenta collagen preparations, method for their extraction and their use |
03/11/1987 | EP0213921A2 Modulation of virus-related events by double-stranded RNAs |
03/11/1987 | EP0213916A2 Protein having phospholipase A2 inhibitory activity |
03/11/1987 | EP0213881A2 The use of amphipathic molecules for radioimaging and therapy with conjugates of monoclonal or polyclonal antibodies |
03/11/1987 | EP0213794A1 Poly-kringle plasminogen activator |
03/11/1987 | EP0213776A2 Use of a cartilage-inducing factor (CIF) for the manufacture of a medicament for treating inflammation |
03/11/1987 | EP0213724A1 A special lipid mixture for membrane fluidization |
03/11/1987 | EP0213676A2 Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies |
03/11/1987 | EP0213581A2 Monoclonal antibodies against tumour-associated glycoproteins, process for their preparation and their use |
03/11/1987 | EP0213499A2 Amino acid derivatives, process for their preparation and use |
03/11/1987 | EP0213481A2 N-terminally substituted dipeptide amides No. 2 |
03/11/1987 | EP0213463A2 Interleukin 2 receptor and a method for its production |
03/11/1987 | EP0213391A2 Antigenic modification of polypeptides |
03/11/1987 | EP0213180A1 Neovascularization inhibitors and methods for their production and use. |
03/11/1987 | EP0092583B1 Telecommunications cable and method of making same |
03/11/1987 | CN86105870A Blood vessel tension peptide protoenzyme inhibitor with 5-amino-2.5-disubstituted-4-hydroxy pentacarboxyl |
03/10/1987 | US4649215 Aliphatic thioethers |
03/10/1987 | US4649191 Conformationally constrained alpha-melanotropin analogs with specific central nervous system activity |
03/10/1987 | US4649132 Treatment of Factor VIII inhibitors |
03/10/1987 | US4649131 Polypeptides |
03/10/1987 | US4649130 Novel derivatives of arginine vasopressin antagonists |
03/10/1987 | US4649047 Ophthalmic treatment by topical administration of cyclosporin |
03/10/1987 | CA1218993A1 3-amino-1-benzazepin-2-one-1-alkanoic acids |
03/10/1987 | CA1218989A1 Certain benzazocinone and benzazoninone derivatives |
03/10/1987 | CA1218931A1 Anti-viral compositions |
03/05/1987 | DE3628352A1 Oral composition |
03/05/1987 | DE3531597A1 Use of preparations containing interferon-gamma (IFN-gamma) for the treatment of psoriatic disorders |
03/04/1987 | EP0213099A2 Medicaments with an antiphlogistic, immunostimulating and cytoprotective effect, their manufacture and their pharmaceutical applications |
03/04/1987 | EP0213072A2 Treatment of chronic imflammatory disease |
03/04/1987 | EP0212914A2 Amplifying the expression of recombinant DNA products |
03/04/1987 | EP0212912A2 Calcitonin analogs with C-therminal D-amino acid substituents |
03/04/1987 | EP0212903A2 Polypeptide derivatives containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
03/04/1987 | EP0212881A1 Antithrombogenic medical material |
03/04/1987 | EP0212880A1 Production of carcinoembryonic antigen |
03/04/1987 | EP0212595A2 Calcium and magnesium complexes of phytohaemagglutinin-polyheteroglycanes, their manufacture and pharmaceutical preparations |
03/04/1987 | EP0212594A2 Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies |
03/04/1987 | EP0212550A2 Substituted dipeptide amides |
03/04/1987 | EP0212532A1 Method for producing fusion proteins |
03/04/1987 | EP0212531A1 Bovine growth hormone releasing factor derivative |
03/04/1987 | EP0212501A2 Therapeutic agent for treating hematopoietic diseases |
03/04/1987 | EP0212489A2 Anabolic activity modulator and uses thereof |
03/04/1987 | EP0212474A2 Bone morphogenetic peptides |
03/04/1987 | EP0212432A2 Calcitonin gene related peptide derivatives |
03/04/1987 | EP0212040A1 Process for producing preparations based on blood coagulation factors |
03/04/1987 | EP0211895A1 Method for purifying antihemophilic factor |
03/04/1987 | CN86105087A Injectable sustained release formulation |
03/03/1987 | US4647656 Antibiotics |
03/03/1987 | US4647655 Method for splitting di-sulphide bonds and a compound obtained thereby |